Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sequential versus concurrent cisplatin-vinorelbine chemoradiotherapy in inoperable stage III non-small cell lung cancer
ISRCTN13746987Phase 3Completed
- Sponsor
- Sponsor not defined
- Start
- Dec 2005
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, open-label trial of cisplatin and vinorelbine in non-small cell lung cancer (NSCLC) (2 arms), sponsored by Sponsor not defined. Primary endpoint: Overall survival. Started Dec 2005; status: completed.
02
Drugs
cisplatinvinorelbine
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on ISRCTN13746987.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN13746987.